Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Functional product with effect of preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof

A cardiovascular and cerebrovascular disease, function technology, applied in the field of functional products with the effect of preventing and treating cardiovascular and cerebrovascular diseases and its preparation, can solve the problems of inability to dissolve old thrombus, single function of traditional Chinese medicine, slow effect, etc. The effect of blood supply to the myocardium and enhancing the toughness and elasticity of blood vessels

Inactive Publication Date: 2021-12-10
中科卫康(广东)生物科技研究中心(有限合伙)
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, drugs for the treatment of cardiovascular and cerebrovascular diseases mainly include western medicine, traditional Chinese medicine and thrombolytic drugs. Western medicine includes aspirin, which is mainly used to reduce platelet aggregation and blood viscosity to achieve therapeutic purposes; while traditional Chinese medicine includes Danshen, ginkgo, etc. It is used to promote blood circulation and remove blood stasis, reduce the number of red blood cells, and regulate blood lipids; thrombolytic drugs include streptokinase, urokinase, etc., and are generally used in rescue; however, Western medicines generally have certain side effects and cause certain damage to the body; Old thrombus cannot be dissolved, and the effect is slow; in addition, cardiovascular and cerebrovascular diseases can also be treated by heart bypass surgery; but the existing surgical treatment is risky, expensive, and requires regular testing

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Functional product with effect of preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] 1. Functional products with the effect of preventing and treating cardiovascular and cerebrovascular diseases

[0048] The above-mentioned functional products with the efficacy of preventing and treating cardiovascular and cerebrovascular diseases include the following raw materials in parts by weight:

[0049] 25 parts of L-arginine, 6 parts of grape seed extract, 30 parts of bromelain, 12 parts of red yeast rice extract, 8 parts of nattokinase, 9 parts of vitamin C, 2 parts of orange powder, 6 parts of maltodextrin, sucrose 3 parts of element, 0.6 part of citric acid and 0.2 part of silicon dioxide,

[0050] Wherein, the grape seed extract is obtained by the following method:

[0051] (a) soaking the grape seeds in water for 4 hours, draining, and pulverizing until the particle size is not greater than 2mm, to obtain grape seed particles;

[0052] (b) Inoculate Aspergillus niger, yeast and lactic acid bacteria into grape seed granules and ferment for 6 days at 27°C,...

Embodiment 2

[0061] 1. Functional products with the effect of preventing and treating cardiovascular and cerebrovascular diseases

[0062] The above-mentioned functional products with the efficacy of preventing and treating cardiovascular and cerebrovascular diseases include the following raw materials in parts by weight:

[0063] 15 parts of L-arginine, 14 parts of grape seed extract, 20 parts of bromelain, 18 parts of red yeast rice extract, 2 parts of nattokinase, 5 parts of vitamin C, 8 parts of orange powder, 15 parts of maltodextrin, 1 part of sucralose, 0.2 part of citric acid and 0.6 part of silicon dioxide,

[0064] Wherein, the grape seed extract is obtained by the following method:

[0065] (a) soaking grape seeds in water for 2 hours, draining, and pulverizing until the particle size is not greater than 2mm, to obtain grape seed particles;

[0066] (b) Inoculate Aspergillus niger, yeast and lactic acid bacteria into grape seed granules and ferment for 4 days at 35°C, turning ...

Embodiment 3

[0075] 1. Functional products with the effect of preventing and treating cardiovascular and cerebrovascular diseases

[0076] The above-mentioned functional products with the efficacy of preventing and treating cardiovascular and cerebrovascular diseases include the following raw materials in parts by weight:

[0077] 22 parts of L-arginine, 8 parts of grape seed extract, 24 parts of bromelain, 16 parts of red yeast rice extract, 6 parts of nattokinase, 6 parts of vitamin C, 6 parts of orange powder, 8 parts of maltodextrin, 3 parts of sucralose, 0.4 parts of citric acid and 0.6 parts of silicon dioxide,

[0078] Wherein, the grape seed extract is obtained by the following method:

[0079] (a) soaking the grape seeds in water for 3 hours, draining, and pulverizing until the particle size is not greater than 2mm, to obtain grape seed particles;

[0080] (b) Inoculate Aspergillus niger, yeast and lactic acid bacteria into grape seed granules and ferment for 5 days at 32°C, tur...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a functional product with effect of preventing and treating cardiovascular and cerebrovascular diseases and a preparation method thereof. The functional product is prepared from the following raw materials in parts by weight: 15 to 25 parts of L-arginine, 6 to 14 parts of grape seed extract, 20 to 30 parts of bromelain, 12 to 18 parts of red yeast rice extract, 2 to 8 parts of nattokinase, 5 to 9 parts of vitamin C, 2 to 8 parts of orange powder and 6 to 15 parts of maltodextrin. According to the functional product, under the combined action of all the raw materials, the cardiovascular and cerebrovascular diseases are prevented and treated from multiple aspects of inhibiting generation of lipid peroxide, decomposing cholesterol, dissolving old thrombus, enhancing toughness and elasticity of blood vessels, enhancing body functions and the like; and therefore, the functional product has rapid and efficient prevention and treatment effects on the cardiovascular and cerebrovascular diseases.

Description

technical field [0001] The invention relates to the technical field of prevention and treatment of blood and cerebrovascular diseases, in particular to a functional product with the effect of preventing and treating cardiovascular and cerebrovascular diseases and a preparation method thereof. Background technique [0002] Cardiovascular and cerebrovascular diseases are collectively referred to as cardiovascular and cerebrovascular diseases. Diseases; the root cause of cardiovascular and cerebrovascular diseases is that the vascular lesions caused by lipid peroxides form thrombus, which leads to lesions in the human brain, heart and its organs and tissues. [0003] The causes of thrombosis mainly include: the higher the content of platelets, red and white blood cells, and fibrin in the blood, the more viscous the blood, and the aggregation of thrombotic factors over time, resulting in thrombus; less exercise, weak heart blood supply function, and blood viscosity. The blood f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/48A61K47/26A61K47/12A61K47/04A61P7/02A61P7/00A61P39/06A61P9/00A61P25/00A61P3/06A61P9/14A61K36/899A61K31/198A61K31/375A61K31/718
CPCA61K31/198A61K36/87A61K38/4873A61K36/899A61K36/062A61K38/482A61K31/375A61K36/752A61K31/718A61K47/26A61K47/12A61K47/02A61P7/02A61P7/00A61P39/06A61P9/00A61P25/00A61P3/06A61P9/14C12Y304/22004C12Y304/21062A61K2236/19A61K2300/00
Inventor 张峰铄周鲁帝
Owner 中科卫康(广东)生物科技研究中心(有限合伙)
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com